OpenURL Connection Search

Select item for more details and to access through your institution.

Developing imidazoles as CEST MRI pH sensors.
Published in:
Contrast Media & Molecular Imaging, 2016, v. 11, n. 4, p. 304, doi. 10.1002/cmmi.1693
By:
- Yang, Xing;
- Song, Xiaolei;
- Ray Banerjee, Sangeeta;
- Li, Yuguo;
- Byun, Youngjoo;
- Liu, Guanshu;
- Bhujwalla, Zaver M.;
- Pomper, Martin G.;
- McMahon, Michael T.
Publication type:
Article
Anthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen.
Published in:
Contrast Media & Molecular Imaging, 2015, v. 10, n. 1, p. 74, doi. 10.1002/cmmi.1597
By:
- Song, Xiaolei;
- Yang, Xing;
- Ray Banerjee, Sangeeta;
- Pomper, Martin G.;
- McMahon, Michael T.
Publication type:
Article
Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.
Published in:
Angewandte Chemie International Edition, 2015, v. 54, n. 37, p. 10778, doi. 10.1002/anie.201503417
By:
- Banerjee, Sangeeta Ray;
- Ngen, Ethel J.;
- Rotz, Matthew W.;
- Kakkad, Samata;
- Lisok, Ala;
- Pracitto, Richard;
- Pullambhatla, Mrudula;
- Chen, Zhengping;
- Shah, Tariq;
- Artemov, Dmitri;
- Meade, Thomas J.;
- Bhujwalla, Zaver M.;
- Pomper, Martin G.
Publication type:
Article
Salicylic Acid and Analogues as diaCEST MRI Contrast Agents with Highly Shifted Exchangeable Proton Frequencies.
Published in:
Angewandte Chemie International Edition, 2013, v. 52, n. 31, p. 8116, doi. 10.1002/anie.201302764
By:
- Yang, Xing;
- Song, Xiaolei;
- Li, Yuguo;
- Liu, Guanshu;
- Ray Banerjee, Sangeeta;
- Pomper, Martin G.;
- McMahon, Michael T.
Publication type:
Article
Synthesis and Evaluation of GdIII-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.
Published in:
Angewandte Chemie, 2015, v. 127, n. 37, p. 10928, doi. 10.1002/ange.201503417
By:
- Banerjee, Sangeeta Ray;
- Ngen, Ethel J.;
- Rotz, Matthew W.;
- Kakkad, Samata;
- Lisok, Ala;
- Pracitto, Richard;
- Pullambhatla, Mrudula;
- Chen, Zhengping;
- Shah, Tariq;
- Artemov, Dmitri;
- Meade, Thomas J.;
- Bhujwalla, Zaver M.;
- Pomper, Martin G.
Publication type:
Article
Salicylic Acid and Analogues as diaCEST MRI Contrast Agents with Highly Shifted Exchangeable Proton Frequencies.
Published in:
Angewandte Chemie, 2013, v. 125, n. 31, p. 8274, doi. 10.1002/ange.201302764
By:
- Yang, Xing;
- Song, Xiaolei;
- Li, Yuguo;
- Liu, Guanshu;
- Ray Banerjee, Sangeeta;
- Pomper, Martin G.;
- McMahon, Michael T.
Publication type:
Article
Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen.
Published in:
Angewandte Chemie, 2011, v. 123, n. 39, p. 9333, doi. 10.1002/ange.201102872
By:
- Banerjee, Sangeeta Ray;
- Pullambhatla, Mrudula;
- Byun, Youngjoo;
- Nimmagadda, Sridhar;
- Foss, Catherine A.;
- Green, Gilbert;
- Fox, James J.;
- Lupold, Shawn E.;
- Mease, Ronnie C.;
- Pomper, Martin G.
Publication type:
Article
A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.
Published in:
Biomolecules (2218-273X), 2022, v. 12, n. 3, p. 405, doi. 10.3390/biom12030405
By:
- Chen, Ying;
- Minn, Il;
- Rowe, Steven P.;
- Lisok, Alla;
- Chatterjee, Samit;
- Brummet, Mary;
- Banerjee, Sangeeta Ray;
- Mease, Ronnie C.;
- Pomper, Martin G.
Publication type:
Article
A convenient solid-phase synthesis methodology for preparing peptide-derived molecular imaging agents — Synthesis, characterization, and in vitro screening of Tc(I) – chemotactic peptide conjugates.
Published in:
Canadian Journal of Chemistry, 2005, v. 83, n. 12, p. 2060, doi. 10.1139/V05-224
By:
- Stephenson, Karin A.;
- Banerjee, Sangeeta Ray;
- McFarlane, Nicole;
- Boreham, Douglas R.;
- Maresca, Kevin P.;
- Babich, John W.;
- Zubieta, Jon;
- Valliant, John F.
Publication type:
Article
Preclinical Evaluation of a New Series of Albumin-Binding 177 Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.
Published in:
Molecules, 2023, v. 28, n. 16, p. 6158, doi. 10.3390/molecules28166158
By:
- Boinapally, Srikanth;
- Alati, Suresh;
- Jiang, Zirui;
- Yan, Yu;
- Lisok, Alla;
- Singh, Rajan;
- Lofland, Gabriela;
- Minn, Il;
- Hobbs, Robert F.;
- Pomper, Martin G.;
- Banerjee, Sangeeta Ray
Publication type:
Article
Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.
Published in:
Chemistry - A European Journal, 2018, v. 24, n. 28, p. 7235, doi. 10.1002/chem.201800882
By:
- Banerjee, Sangeeta Ray;
- Song, Xiaolei;
- Yang, Xing;
- Minn, Il;
- Lisok, Ala;
- Chen, Yanrong;
- Bui, Albert;
- Chatterjee, Samit;
- Chen, Jian;
- van Zijl, Peter C. M.;
- McMahon, Michael T.;
- Pomper, Martin G.
Publication type:
Article
Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1432286
By:
- Singh, Rajan;
- Thotakura, Anand K.;
- Alati, Suresh;
- Lisok, Alla;
- Zirui Jiang;
- Merino, Vanessa F.;
- Minn, Il;
- Yadav, Santosh;
- Markowski, Mark C.;
- Ged, Yasser;
- Pavlovich, Christian P.;
- Singla, Nirmish;
- Solnes, Lilja B.;
- Gorin, Michael A.;
- Pomper, Martin G.;
- Rowe, Steven P.;
- Banerjee, Sangeeta Ray
Publication type:
Article
Editorial: Theranostics as a driving force in nuclear medicine.
Published in:
Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1468357
By:
- Rowe, Steven P.;
- Werner, Rudolf A.;
- Banerjee, Sangeeta Ray
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Kang, Choong Mo;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Minn, Il;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Feng, Yutian;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Choong Mo Kang;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Minn, Il;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Yutian Feng;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Kang, Choong Mo;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Minn, Il;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Feng, Yutian;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Choong Mo Kang;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Il Minn;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Yutian Feng;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Choong Mo Kang;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Il Minn;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Yutian Feng;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
An improved 211At-labeled agent for PSMA-targeted alpha therapy.
Published in:
Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 1, doi. 10.2967/jnumed.121.262098
By:
- Mease, Ronnie C.;
- Choong Mo Kang;
- Kumar, Vivek;
- Banerjee, Sangeeta Ray;
- Il Minn;
- Brummet, Mary;
- Gabrielson, Kathleen L.;
- Feng, Yutian;
- Park, Andrew;
- Kiess, Ana P.;
- Sgouros, George;
- Vaidyanathan, Ganesan;
- Zalutsky, Michael R.;
- Pomper, Martin G.
Publication type:
Article
Preclinical evaluation of 213Bi-/225Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.
Published in:
Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.256388
By:
- Banerjee, Sangeeta Ray;
- Lisok, Ala;
- Minn, Il;
- Josefsson, Anders;
- Kumar, Vivek;
- Brummet, Mary;
- Boinapally, Srikanth;
- Brayton, Cory;
- Mease, Ronnie C.;
- Sgouros, George;
- Hobbs, Robert F.;
- Pomper, Martin G.
Publication type:
Article
Preclinical evaluation of 203/212Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.229393
By:
- Banerjee, Sangeeta Ray;
- Il Minn;
- Kumar, Vivek;
- Josefsson, Anders;
- Lisok, Ala;
- Brummet, Mary;
- Jian Chen;
- Kiess, Ana P.;
- Baidoo, Kwamena;
- Brayton, Cory;
- Mease, Ronnie C.;
- Brechbiel, Martin;
- Sgouros, George;
- Hobbs, Robert F.;
- Pomper, Martin G.
Publication type:
Article
Evaluation of 111In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.
Published in:
Journal of Nuclear Medicine, 2019, v. 60, n. 3, p. 400, doi. 10.2967/jnumed.118.214403
By:
- Banerjee, Sangeeta Ray;
- Kumar, Vivek;
- Lisok, Ala;
- Plyku, Donika;
- Nováková, Zora;
- Brummet, Mary;
- Wharram, Bryan;
- Barinka, Cyril;
- Hobbs, Robert;
- Pomper, Martin G.
Publication type:
Article
Preclinical Evaluation of 86Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates.
Published in:
Journal of Nuclear Medicine, 2015, v. 56, n. 4, p. 628, doi. 10.2967/jnumed.114.149062
By:
- Banerjee, Sangeeta Ray;
- Foss, Catherine A.;
- Pullambhatla, Mrudula;
- Yuchuan Wang;
- Srinivasan, Senthamizhchelvan;
- Hobbs, Robert F.;
- Baidoo, Kwamena E.;
- Brechbiel, Martin W.;
- Nimmagadda, Sridhar;
- Mease, Ronnie C.;
- Sgouros, George;
- Pomper, Martin G.
Publication type:
Article
Tuning Phenols with Intra-Molecular Bond Shifted HYdrogens (IM-SHY) as diaCEST MRI Contrast Agents.
Published in:
Chemistry - A European Journal, 2014, v. 20, n. 48, p. 15824, doi. 10.1002/chem.201403943
By:
- Yang, Xing;
- Yadav, Nirbhay N.;
- Song, Xiaolei;
- Ray Banerjee, Sangeeta;
- Edelman, Hannah;
- Minn, Il;
- van Zijl, Peter C. M.;
- Pomper, Martin G.;
- McMahon, Michael T.
Publication type:
Article
Correction to: Hetero-bivalent agents targeting FAP and PSMA.
Published in:
2022
By:
- Boinapally, Srikanth;
- Lisok, Alla;
- Lofland, Gabriela;
- Minn, Il;
- Yan, Yu;
- Jiang, Zirui;
- Shin, Min Jay;
- Merino, Vanessa F.;
- Zheng, Lei;
- Brayton, Cory;
- Pomper, Martin G.;
- Banerjee, Sangeeta Ray
Publication type:
Correction Notice
Hetero-bivalent agents targeting FAP and PSMA.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 13, p. 4369, doi. 10.1007/s00259-022-05933-3
By:
- Boinapally, Srikanth;
- Lisok, Alla;
- Lofland, Gabriela;
- Minn, Il;
- Yan, Yu;
- Jiang, Zirui;
- Shin, Min Jay;
- Merino, Vanessa F.;
- Zheng, Lei;
- Brayton, Cory;
- Pomper, Martin G.;
- Banerjee, Sangeeta Ray
Publication type:
Article
177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 12, p. 2545, doi. 10.1007/s00259-019-04434-0
By:
- Banerjee, Sangeeta Ray;
- Kumar, Vivek;
- Lisok, Ala;
- Chen, Jian;
- Minn, Il;
- Brummet, Mary;
- Boinapally, Srikanth;
- Cole, Michael;
- Ngen, Ethel;
- Wharram, Bryan;
- Brayton, Cory;
- Hobbs, Robert F.;
- Pomper, Martin G.
Publication type:
Article
Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen.
Published in:
Angewandte Chemie International Edition, 2011, v. 50, n. 39, p. 9167, doi. 10.1002/anie.201102872
By:
- Banerjee, Sangeeta Ray;
- Pullambhatla, Mrudula;
- Byun, Youngjoo;
- Nimmagadda, Sridhar;
- Foss, Catherine A.;
- Green, Gilbert;
- Fox, James J.;
- Lupold, Shawn E.;
- Mease, Ronnie C.;
- Pomper, Martin G.
Publication type:
Article

Found: 28

Developing imidazoles as CEST MRI pH sensors.

Anthranilic acid analogs as diamagnetic CEST MRI contrast agents that feature an intramolecular-bond shifted hydrogen.

Synthesis and Evaluation of Gd<sup>III</sup>-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.

Salicylic Acid and Analogues as diaCEST MRI Contrast Agents with Highly Shifted Exchangeable Proton Frequencies.

Synthesis and Evaluation of Gd<sup>III</sup>-Based Magnetic Resonance Contrast Agents for Molecular Imaging of Prostate-Specific Membrane Antigen.

Salicylic Acid and Analogues as diaCEST MRI Contrast Agents with Highly Shifted Exchangeable Proton Frequencies.

Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen.

A Series of PSMA-Targeted Near-Infrared Fluorescent Imaging Agents.

A convenient solid-phase synthesis methodology for preparing peptide-derived molecular imaging agents — Synthesis, characterization, and in vitro screening of Tc(I) – chemotactic peptide conjugates.

Preclinical Evaluation of a New Series of Albumin-Binding 177 Lu-Labeled PSMA-Based Low-Molecular-Weight Radiotherapeutics.

Salicylic Acid-Based Polymeric Contrast Agents for Molecular Magnetic Resonance Imaging of Prostate Cancer.

Performance of PSMA-targeted radiotheranostics in an experimental model of renal cell carcinoma.

Editorial: Theranostics as a driving force in nuclear medicine.

An improved 211At-labeled agent for PSMA-targeted alpha therapy.

An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.

An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.

An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.

An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.

An improved <sup>211</sup>At-labeled agent for PSMA-targeted alpha therapy.

Preclinical evaluation of <sup>213</sup>Bi-/<sup>225</sup>Ac-labeled low-molecular-weight compounds for radiopharmaceutical therapy of prostate cancer.

Preclinical evaluation of <sup>203/212</sup>Pb-labeled low-molecular-weight compounds for targeted radiopharmaceutical therapy of prostate cancer.

Evaluation of <sup>111</sup>In-DOTA-5D3, a Surrogate SPECT Imaging Agent for Radioimmunotherapy of Prostate-Specific Membrane Antigen.

Preclinical Evaluation of <sup>86</sup>Y-Labeled Inhibitors of Prostate-Specific Membrane Antigen for Dosimetry Estimates.

Tuning Phenols with Intra-Molecular Bond Shifted HYdrogens (IM-SHY) as diaCEST MRI Contrast Agents.

Correction to: Hetero-bivalent agents targeting FAP and PSMA.

Hetero-bivalent agents targeting FAP and PSMA.

<sup>177</sup>Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy.

Sequential SPECT and Optical Imaging of Experimental Models of Prostate Cancer with a Dual Modality Inhibitor of the Prostate-Specific Membrane Antigen.